Insmed

Yahoo Finance • 6 days ago

Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO

(RTTNews) - The biotech industry witnessed several key events this week, including major FDA approvals, acquisitions, pivotal clinical trial results and setbacks. • A series of FDA approvals were announced during the week, with GSK, Haloz... Full story

Yahoo Finance • 6 days ago

Catalyst Watch: Santa Claus Effect, M&A votes on Electronic Arts and TrueCar, index shuffling

[Futuristic display screen with a bar graph and colorful spreadsheet financial data] matejmo Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that... Full story

Yahoo Finance • 7 days ago

US Stock Market Today: S&P 500 Futures Rise amid Global Rate Hikes, Cooling Inflation

The Morning Bull - US Market Morning Update Friday, Dec, 19 2025 US stock futures are pointing higher this morning, with benchmark contracts up about 0.3 percent, as investors weigh two big global signals. In Japan, the central bank just... Full story

Yahoo Finance • 7 days ago

Stocks Settle Higher on Upbeat Tech Outlook and Cooling Inflation

The S&P 500 Index ($SPX) (SPY) on Thursday closed up by +0.79%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up by +0.14%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up by +1.51%.  December E-mini S&P futures (ESZ25) rose +0.74%... Full story

Yahoo Finance • 7 days ago

Stocks Rally as Chip Makers Soar and US Price Pressures Ease

The S&P 500 Index ($SPX) (SPY) today is up by +1.28%, the Dow Jones Industrials Index ($DOWI) (DIA) is up by +0.82%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up by +1.91%.  December E-mini S&P futures (ESZ25) are up +1.27%, and December E... Full story

Yahoo Finance • 8 days ago

These Stocks Are Moving the Most Today: Micron, Sandisk, DJT, Lululemon, Insmed, Coinbase, Rivian, CarMax, and More

Shares in memory-chip makers Micron and Sandisk are rallying after Micron tops Wall Street's earnings estimates. Continue Reading... Full story

Yahoo Finance • 8 days ago

Insmed Stock Plummets 19%. This Is What Sparked the Selloff.

The biopharmaceutical company said it was discontinuing development of a drug treating a chronic sinus condition. Continue Reading... Full story

Yahoo Finance • 10 days ago

Validea Detailed Fundamental Analysis - INSM

Below is Validea's guru fundamental report for INSMED INC (INSM). Of the 22 guru strategies we follow, INSM rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. This momentum model looks fo... Full story

Yahoo Finance • 10 days ago

MicroStrategy retains place in key index despite delisting threats

Michael Saylor's Bitcoin (BTC) treasury company, Strategy (Nasdaq: MSTR), earlier known as MicroStrategy, has been successful in retaining its spot in the Nasdaq 100 (NDQ). A benchmark stock market index in the U.S., the Nasdaq 100 tracks... Full story

Yahoo Finance • 11 days ago

200% Surge? These 6 Stocks Just Crashed the Nasdaq 100 Party

This article first appeared on GuruFocus. Nasdaq officials have outlined a reshaping of the Nasdaq 100 that could redirect investor attention as the index approaches its annual reconstitution. Ahead of the market open on Dec. 22, Alnylam... Full story

Yahoo Finance • 13 days ago

Lululemon, Biogen to exit Nasdaq 100 with Alnylam, Seagate among additions

[The NASDAQ Stock Exchange headquarters in New York, USA] JHVEPhoto Six companies, including Alnylam Pharmaceuticals (ALNY [https://seekingalpha.com/symbol/ALNY]) and Seagate Technology Holdings (STX [https://seekingalpha.com/symbol/STX])... Full story

Yahoo Finance • 13 days ago

Annual Changes to the Nasdaq-100 Index®

Nasdaq, Inc. NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NDX®), which will become effective prior to market open on Monday, December... Full story

Yahoo Finance • 15 days ago

Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks

Neilson Barnard / Getty Images Entertainment via Getty Images Quick Read Natera (NTRA) grew revenue 34.66% year-over-year in Q3 2025 and has rallied nearly 70% since Q3 2025. Druckenmiller holds $517.4M in Natera. Insmed (INSM) revenue s... Full story

Yahoo Finance • 26 days ago

30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks

Key Points Druckenmiller invests his personal and family's wealth through his fund, the Duquesne Family Office. Druckenmiller is high on biotech stocks, with his top three holdings at the end of the third quarter all in the sector. Biotec... Full story

Yahoo Finance • 26 days ago

INSM Quantitative Stock Analysis

Below is Validea's guru fundamental report for INSMED INC (INSM). Of the 22 guru strategies we follow, INSM rates highest using our Quantitative Momentum Investor model based on the published strategy of Wesley Gray. This momentum model l... Full story

Yahoo Finance • last month

Insmed (INSM) Rose Following Drug Approval

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the third quarter, the equity markets continue... Full story

Yahoo Finance • last month

This Investor Beat the Market for 3 Decades Without a Single Losing Year. 3 Stocks He’s Buying Now.

Neilson Barnard / Getty Images Entertainment via Getty Images Quick Read Druckenmiller produced 30% average annual returns with no losing years at Duquesne from 1981 to 2010. Natera (NTRA) revenue rose 35% year-over-year in Q3 2025 and b... Full story

Yahoo Finance • last month

Here’s What Lifted Insmed Incorporated (INSM) in Q3

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equities continue to rally in the third quarter, the period w... Full story

Yahoo Finance • last month

Stanley Druckenmiller's Strategic Moves: Exiting Philip Morris International Inc with a -3. ...

This article first appeared on GuruFocus. Insights into Stanley Druckenmiller (Trades, Portfolio)'s Third Quarter 2025 Portfolio Adjustments Warning! GuruFocus has detected 6 Warning Signs with NTRA. Is NTRA fairly valued? Test your thes... Full story

Yahoo Finance • 2 months ago

MSCI Equity Indexes November 2025 Index Review

LONDON, November 06, 2025--(BUSINESS WIRE)--MSCI Inc. announced the results of the November 2025 Index Review for the MSCI Equity Indexes. All changes will be implemented as of the close of November 24, 2025. Highlights include: MSCI Glo... Full story